🇪🇺 Raxtozinameran 6 months to 4 years of age in European Union

Raxtozinameran 6 months to 4 years of age (raxtozinameran-6-months-to-4-years-of-age) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Raxtozinameran 6 months to 4 years of age in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in European Union

Frequently asked questions

Is Raxtozinameran 6 months to 4 years of age approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Raxtozinameran 6 months to 4 years of age in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.